Sterne Agee Expects Allergan to Resist Hostile Takeover by Valeant
April 22, 2014 at 09:30 AM EDT
In a report published Tuesday, Sterne Agee analyst Shibani Malhotra reiterated a Buy rating and $142.00 price target on Allergan (NYSE: ...